comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Association of glucagon-like peptide-1 receptor in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes

Commonly used GLP-1 drugs Here are some of the most common GLP-1 medications used for blood sugar and weight management

Respondents had an average age of 42.6 years and were 54.4% female, 45.1% male, and 0.5% nonbinary, representing all 50 states and the District of Columbia

Furthermore, analyses from adverse reporting systems are useful, but are difficult to control for confounding factors that increase the risk of pancreatitis and cancer, such as obesity, alcohol consumption, smoking, and the use of other drugs

Dulaglutide not only achieved glycemic control but also significantly reduced IL-6 and TNF levels and slowed the progression of kidney disease (Tuttle et al

American College of Cardiology